Quang X Pham, Chairman, CEO and Interim CFO at Cadrenal Therapeutics, sold CVKD on Jun 11, 2026
Data as of Oct 27
▼ SELL$6K1,462 shares at $4.12Quang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.
- Traded
- Jun 11, 2026
- Disclosed
- Jun 15, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CVKD since disclosure
−71.7%
after the sale
Similar stocks (XLV) since disclosure
+17.2%
XLV — its sector index fund
Change in closing price from Jun 15, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLQuang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.$13.1Kdisclosed Jun 15 · filed the same day
- ▼ SELLQuang X Pham Chairman, CEO and Interim CFOCVKD Cadrenal Therapeutics, Inc.$51.2Kdisclosed Jun 15 · filed 3 days after the trade